PRMT5 expression was variable in CLL patients who did not undergo transformation, ranging from not expressed to weakly expressed, whereas PRMT5 was consistently overexpressed in pre-RT patients (Fig. 1b). The gene discussed is PRMT5; the disease is B-cell chronic lymphocytic leukemia.